{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:16:25Z","timestamp":1783296985352,"version":"3.54.6"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to clarify how cancer-associated fibroblast-derived exosomal circ_0067557 (CAF-exo circ_0067557) promotes epithelial-mesenchymal transition (EMT) in colorectal cancer (CRC) through BHLHE40-mediated transcriptional activation of OTUB2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CAF-derived exosomes were isolated and characterized from CRC tissues, while normal fibroblast-derived exosomes were obtained from adjacent normal tissues. The transfer of circ_0067557 was tracked using fluorescence labeling and endocytosis assays. Expression of circ_0067557, BHLHE40, OTUB2, and EMT-related markers was assessed by qRT-PCR, Western blotting, and immunofluorescence. Gain- and loss-of-function models were established to determine the biological role of circ_0067557. RNA sequencing identified OTUB2 as a key downstream target. ChIP-qPCR and dual-luciferase reporter assays were performed to verify BHLHE40 binding to the OTUB2 promoter. RIP and RNA pull-down assays confirmed the interaction between circ_0067557 and BHLHE40. Mouse xenograft and tail vein metastasis models were used to evaluate the oncogenic effects of circ_0067557 in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CAF-exos successfully delivered circ_0067557 into CRC cells, significantly enhancing their proliferative, migratory, invasive, and EMT capabilities. Mechanistically, circ_0067557 interacted with and recruited BHLHE40, thereby increasing its binding to the OTUB2 promoter and promoting OTUB2 transcription. In vivo experiments further confirmed that circ_0067557 markedly enhanced tumor growth and distant metastasis through the BHLHE40\/OTUB2 signaling axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CAF-exo circ_0067557 promotes EMT, invasion, metastasis, and tumor progression in CRC by recruiting BHLHE40 and activating OTUB2 transcription. These findings reveal a novel mechanism by which the tumor microenvironment (TME) regulates cancer cell metastasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13062-026-00805-4","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:05:14Z","timestamp":1778497514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer-associated fibroblasts-derived exosomal circ_0067557 promotes colorectal cancer epithelial-mesenchymal transition via BHLHE40-mediated transcriptional activation of OTUB2"],"prefix":"10.1186","volume":"21","author":[{"given":"Daoxu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"4","key":"805_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3760\/cma.j.cn112152-20240308-00102","volume":"47","author":"JJ Li","year":"2025","unstructured":"Li JJ, Zhang YM, Ji YT, Wu J, Jin QY, Feng ZW, Duan HY, Liu XM, Lyu ZY, Song FJ, Huang YB. Comparison analyses of global burden of colorectal cancer. Zhonghua Zhong Liu Za Zhi. 2025;47(4):308\u201315. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20240308-00102.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"10207","key":"805_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/s0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(19)32319-0.","journal-title":"Lancet"},{"issue":"9","key":"805_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","volume":"21","author":"A Ca\u00f1ellas-Socias","year":"2024","unstructured":"Ca\u00f1ellas-Socias A, Sancho E, Batlle E. Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2024;21(9):609\u201325. https:\/\/doi.org\/10.1038\/s41575-024-00934-z.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8047","key":"805_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41586-024-08150-0","volume":"637","author":"A Moorman","year":"2024","unstructured":"Moorman A, Benitez EK, Cambulli F, et al. Progressive plasticity during colorectal cancer metastasis. Nature. 2024;637(8047):947\u201354. https:\/\/doi.org\/10.1038\/s41586-024-08150-0.","journal-title":"Nature"},{"issue":"192","key":"805_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.24976\/discov.med.202537192.15","volume":"37","author":"Q Luo","year":"2025","unstructured":"Luo Q, Zhu B, Wang C, Wang Y. CKAP2L Plays a Pivotal Role in Colorectal Cancer Progression via the Dual Regulation of Cell Cycle and Epithelial-Mesenchymal Transition. Discov Med. 2025;37(192):182. https:\/\/doi.org\/10.24976\/discov.med.202537192.15.","journal-title":"Discov Med"},{"key":"805_CR6","doi-asserted-by":"publisher","unstructured":"Barjasteh A, Abdolamir AH, Al-Asady AM, et al. Embracing the circular journey of RNA in colorectal cancer. CCDT. 2025;25. https:\/\/doi.org\/10.2174\/0115680096324880250117062148.","DOI":"10.2174\/0115680096324880250117062148"},{"key":"805_CR7","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753.","journal-title":"Pharmacol Ther"},{"key":"805_CR8","doi-asserted-by":"publisher","unstructured":"gianni. Tumor microenvironment: recent advances in various cancer treatments. Eur Rev Published online June. 2018;27. https:\/\/doi.org\/10.26355\/eurrev_201806_15270.","DOI":"10.26355\/eurrev_201806_15270"},{"issue":"6","key":"805_CR9","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy. Mol Cell. 2020;78(6):1019\u201333. https:\/\/doi.org\/10.1016\/j.molcel.2020.05.034.","journal-title":"Mol Cell"},{"key":"805_CR10","doi-asserted-by":"publisher","unstructured":"Ma C, Yang C, Peng A, et al. Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment. Mol Cancer. 2023;22(1). https:\/\/doi.org\/10.1186\/s12943-023-01876-x.","DOI":"10.1186\/s12943-023-01876-x"},{"key":"805_CR11","doi-asserted-by":"publisher","unstructured":"Zhang H, Yue X, Chen Z, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22(1). https:\/\/doi.org\/10.1186\/s12943-023-01860-5.","DOI":"10.1186\/s12943-023-01860-5"},{"issue":"7","key":"805_CR12","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s43018-022-00411-z","volume":"3","author":"D Lavie","year":"2022","unstructured":"Lavie D, Ben-Shmuel A, Erez N, Scherz-Shouval R. Cancer-associated fibroblasts in the single-cell era. Nat Cancer. 2022;3(7):793\u2013807. https:\/\/doi.org\/10.1038\/s43018-022-00411-z.","journal-title":"Nat Cancer"},{"key":"805_CR13","doi-asserted-by":"publisher","unstructured":"Chen X, Jia M, Ji J, Zhao Z, Zhao Y. Exosome-derived non-coding RNAs in the tumor microenvironment of colorectal cancer: possible functions, mechanisms and clinical applications. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.887532.","DOI":"10.3389\/fonc.2022.887532"},{"key":"805_CR14","doi-asserted-by":"publisher","unstructured":"Yang P, Zhang D, Wang T, et al. CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. Cell Death Dis. 2022;13(9). https:\/\/doi.org\/10.1038\/s41419-022-05240-7.","DOI":"10.1038\/s41419-022-05240-7"},{"key":"805_CR15","doi-asserted-by":"publisher","unstructured":"Wu Z, Ju Q. Non-coding RNAs implicated in the tumor microenvironment of colorectal cancer: roles, mechanisms and clinical study. Front Oncol. 2022;12. https:\/\/doi.org\/10.3389\/fonc.2022.888276.","DOI":"10.3389\/fonc.2022.888276"},{"key":"805_CR16","doi-asserted-by":"publisher","unstructured":"Ren L, Jiang Q, Mo L, et al. Mechanisms of circular RNA degradation. Commun Biol. 2022;5(1). https:\/\/doi.org\/10.1038\/s42003-022-04262-3.","DOI":"10.1038\/s42003-022-04262-3"},{"issue":"4","key":"805_CR17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","volume":"26","author":"E O\u2019Leary","year":"2025","unstructured":"O\u2019Leary E, Jiang Y, Kristensen LS, Hansen TB, Kjems J. The therapeutic potential of circular RNAs. Nat Rev Genet. 2025;26(4):230\u201344. https:\/\/doi.org\/10.1038\/s41576-024-00806-x.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"805_CR18","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1261\/rna.047126.114","volume":"20","author":"E Lasda","year":"2014","unstructured":"Lasda E, Parker R. Circular RNAs: diversity of form and function. RNA. 2014;20(12):1829\u201342. https:\/\/doi.org\/10.1261\/rna.047126.114.","journal-title":"RNA"},{"issue":"6","key":"805_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.7150\/ijms.71840","volume":"19","author":"X Zhao","year":"2022","unstructured":"Zhao X, Zhong Y, Wang X, Shen J, An W. Advances in Circular RNA and Its Applications. Int J Med Sci. 2022;19(6):975\u201385. https:\/\/doi.org\/10.7150\/ijms.71840.","journal-title":"Int J Med Sci"},{"issue":"4","key":"805_CR20","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/1878-0261.12468","volume":"13","author":"L Verduci","year":"2019","unstructured":"Verduci L, Strano S, Yarden Y, Blandino G. The circRNA\u2013microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669\u201380. https:\/\/doi.org\/10.1002\/1878-0261.12468.","journal-title":"Mol Oncol"},{"key":"805_CR21","doi-asserted-by":"publisher","unstructured":"Wang Y, Yan Q, Mo Y, et al. Splicing factor derived circular RNA circCAMSAP1 accelerates nasopharyngeal carcinoma tumorigenesis via a SERPINH1\/c-Myc positive feedback loop. Mol Cancer. 2022;21(1). https:\/\/doi.org\/10.1186\/s12943-022-01502-2.","DOI":"10.1186\/s12943-022-01502-2"},{"issue":"1","key":"805_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","volume":"73","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Du J, Wang S, et al. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. Mol Cell. 2019;73(1):7\u2013e217. https:\/\/doi.org\/10.1016\/j.molcel.2018.10.030.","journal-title":"Mol Cell"},{"issue":"11","key":"805_CR23","first-page":"5382","volume":"13","author":"X Xu","year":"2023","unstructured":"Xu X, Wu G, Han K, et al. Inhibition of OTUB2 suppresses colorectal cancer cell growth by regulating \u03b2-Catenin signaling. Am J Cancer Res. 2023;13(11):5382\u201393.","journal-title":"Am J Cancer Res"},{"issue":"13","key":"805_CR24","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1158\/0008-5472.can-23-3264","volume":"84","author":"S Yang","year":"2024","unstructured":"Yang S, Zhang D, Sun Q, et al. Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer. Cancer Res. 2024;84(13):2202\u201317. https:\/\/doi.org\/10.1158\/0008-5472.can-23-3264.","journal-title":"Cancer Res"},{"key":"805_CR25","doi-asserted-by":"publisher","unstructured":"Wang J, Li B, Yang S, et al. Upregulation of INHBA mediated by the transcription factor BHLHE40 promotes colon cancer cell proliferation and migration. Clin Lab Anal. 2022;36(7). https:\/\/doi.org\/10.1002\/jcla.24539.","DOI":"10.1002\/jcla.24539"},{"key":"805_CR26","doi-asserted-by":"publisher","unstructured":"Sui Y, Jiang H, Kellogg CM, Oh S, Janknecht R. Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of ADAM19 and KLF7. Front Oncol. 2023;13. https:\/\/doi.org\/10.3389\/fonc.2023.1122238.","DOI":"10.3389\/fonc.2023.1122238"},{"key":"805_CR27","doi-asserted-by":"publisher","unstructured":"Yang C, Zhang Y, Yan M, et al. Exosomes derived from cancer-associated fibroblasts promote tumorigenesis, metastasis and chemoresistance of colorectal cancer by upregulating circ_0067557 to target Lin28. BMC Cancer. 2024;24(1). https:\/\/doi.org\/10.1186\/s12885-023-11791-5.","DOI":"10.1186\/s12885-023-11791-5"},{"key":"805_CR28","doi-asserted-by":"publisher","first-page":"102293","DOI":"10.1016\/j.bbrep.2025.102293","volume":"44","author":"S Khakshournia","year":"2025","unstructured":"Khakshournia S, Siri M, Zamani M, et al. Deactivation of CK1\u03b1 enhances the anti-cancer effects of salinomycin in colorectal cancer HCT116 cells. Biochem Biophys Rep. 2025;44:102293. https:\/\/doi.org\/10.1016\/j.bbrep.2025.102293.","journal-title":"Biochem Biophys Rep"},{"key":"805_CR29","doi-asserted-by":"publisher","unstructured":"Jabbar S, Mathews P, Wang X, et al. Thioredoxin-1 regulates self-renewal and differentiation of murine hematopoietic stem cells through p53 tumor suppressor. Exp Hematol Oncol. 2022;11(1). https:\/\/doi.org\/10.1186\/s40164-022-00329-3.","DOI":"10.1186\/s40164-022-00329-3"},{"issue":"11","key":"805_CR30","doi-asserted-by":"publisher","first-page":"e31584","DOI":"10.1016\/j.heliyon.2024.e31584","volume":"10","author":"N Payervand","year":"2024","unstructured":"Payervand N, Pakravan K, Razmara E, et al. Exosomal circ_0084043 derived from colorectal cancer-associated fibroblasts promotes in vitro endothelial cell angiogenesis by regulating the miR-140\u20133p\/HIF-1\u03b1\/VEGF signaling axis. Heliyon. 2024;10(11):e31584. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31584.","journal-title":"Heliyon"},{"key":"805_CR31","doi-asserted-by":"publisher","unstructured":"Zhou B, Wang H, Zhang K, et al. Suppression of circ_0091761 ameliorates acute myocardial infarction-induced endothelial injury through regulation of miR-1278. Hereditas. 2025;162(1). https:\/\/doi.org\/10.1186\/s41065-025-00519-z.","DOI":"10.1186\/s41065-025-00519-z"},{"key":"805_CR32","doi-asserted-by":"publisher","unstructured":"Zhou Y, Guo Y. Circ-PSMB1 knockdown inhibits the pyroptosis of ox-LDL treated human aortic cells via the miR-624-3p\/ASC axis. J Cardiothorac Surg. 2025;20(1). https:\/\/doi.org\/10.1186\/s13019-025-03457-z.","DOI":"10.1186\/s13019-025-03457-z"},{"issue":"8","key":"805_CR33","doi-asserted-by":"publisher","first-page":"e3011","DOI":"10.1038\/cddis.2017.421","volume":"8","author":"Dliang Chen","year":"2017","unstructured":"Chen Dliang, Chen L, zong, Lu Y, xin, et al. Long noncoding RNA XIST expedites metastasis and modulates epithelial\u2013mesenchymal transition in colorectal cancer. Cell Death Dis. 2017;8(8):e3011\u20133011. https:\/\/doi.org\/10.1038\/cddis.2017.421.","journal-title":"Cell Death Dis"},{"key":"805_CR34","doi-asserted-by":"publisher","unstructured":"Gong Y, Liu Z, Yuan Y, et al. PUMILIO proteins promote colorectal cancer growth via suppressing p21. Nat Commun. 2022;13(1). https:\/\/doi.org\/10.1038\/s41467-022-29309-1.","DOI":"10.1038\/s41467-022-29309-1"},{"key":"805_CR35","doi-asserted-by":"publisher","unstructured":"Zhong X, He X, Wang Y, et al. Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications. J Hematol Oncol. 2022;15(1). https:\/\/doi.org\/10.1186\/s13045-022-01358-5.","DOI":"10.1186\/s13045-022-01358-5"},{"key":"805_CR36","doi-asserted-by":"publisher","unstructured":"Mei Y, Xiao W, Hu H, et al. Single-cell analyses reveal suppressive tumor microenvironment of human colorectal cancer. Clin Translational Med. 2021;11(6). https:\/\/doi.org\/10.1002\/ctm2.422.","DOI":"10.1002\/ctm2.422"},{"issue":"5","key":"805_CR37","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","volume":"24","author":"S Kamali Zonouzi","year":"2021","unstructured":"Kamali Zonouzi S, Pezeshki PS, Razi S, Rezaei N. Cancer-associated fibroblasts in colorectal cancer. Clin Transl Oncol. 2021;24(5):757\u201369. https:\/\/doi.org\/10.1007\/s12094-021-02734-2.","journal-title":"Clin Transl Oncol"},{"issue":"17","key":"805_CR38","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.7150\/thno.72853","volume":"12","author":"A Giguelay","year":"2022","unstructured":"Giguelay A, Turtoi E, Khelaf L, et al. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. Theranostics. 2022;12(17):7624\u201339. https:\/\/doi.org\/10.7150\/thno.72853.","journal-title":"Theranostics"},{"key":"805_CR39","doi-asserted-by":"publisher","unstructured":"Yang K, Zhang J, Bao C. Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214\/PD-L1 axis. BMC Cancer. 2021;21(1). https:\/\/doi.org\/10.1186\/s12885-021-08669-9.","DOI":"10.1186\/s12885-021-08669-9"},{"key":"805_CR40","doi-asserted-by":"publisher","unstructured":"Malviya A, Bhuyan R. Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas. Discov Onc. 2025;16(1). https:\/\/doi.org\/10.1007\/s12672-025-01743-9.","DOI":"10.1007\/s12672-025-01743-9"},{"issue":"9","key":"805_CR41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24(9):597\u2013613. https:\/\/doi.org\/10.1038\/s41568-024-00721-7.","journal-title":"Nat Rev Cancer"},{"key":"805_CR42","doi-asserted-by":"publisher","unstructured":"Nambidi S, Shruthi KB, Kanimozhe SP, et al. A review of circular RNAs in colorectal cancer: insights into biomarker discovery and therapeutic targeting. Front Oncol. 2025;15. https:\/\/doi.org\/10.3389\/fonc.2025.1549046.","DOI":"10.3389\/fonc.2025.1549046"},{"issue":"7","key":"805_CR43","first-page":"3972","volume":"11","author":"X Liu","year":"2019","unstructured":"Liu X, Liu L, Dong Z, et al. Expression patterns and prognostic value of m6A-related genes in colorectal cancer. Am J Transl Res. 2019;11(7):3972\u201391.","journal-title":"Am J Transl Res"},{"key":"805_CR44","doi-asserted-by":"publisher","unstructured":"Wang W, Jia W, Du Y, Zhao D, Shi C. Identification of TMEM59L as a potential diagnosis, prognosis and immunotherapy biomarker for colon adenocarcinoma. Sci Rep. 2026;16(1). https:\/\/doi.org\/10.1038\/s41598-026-36478-2.","DOI":"10.1038\/s41598-026-36478-2"},{"key":"805_CR45","doi-asserted-by":"publisher","unstructured":"Wang A, Zhou Y, Deng Z, Duan Y, Dai Z, Jiang D. Comprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy. Front Immunol. 2026;16. https:\/\/doi.org\/10.3389\/fimmu.2025.1719525.","DOI":"10.3389\/fimmu.2025.1719525"},{"issue":"45","key":"805_CR46","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.18632\/oncotarget.27061","volume":"10","author":"K Asanoma","year":"2019","unstructured":"Asanoma K, Hori E, Yoshida S, et al. Mutual suppression between BHLHE40\/BHLHE41 and the MIR301B-MIR130B cluster is involved in epithelial-to-mesenchymal transition of endometrial cancer cells. Oncotarget. 2019;10(45):4640\u201354. https:\/\/doi.org\/10.18632\/oncotarget.27061.","journal-title":"Oncotarget"},{"issue":"24","key":"805_CR47","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1128\/mcb.00678-15","volume":"35","author":"K Asanoma","year":"2015","unstructured":"Asanoma K, Liu G, Yamane T, et al. Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells. Mol Cell Biol. 2015;35(24):4096\u2013109. https:\/\/doi.org\/10.1128\/mcb.00678-15.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"805_CR48","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3892\/ijo.2012.1559","volume":"41","author":"Y WU","year":"2012","unstructured":"WU Y, SATO F, YAMADA T, et al. The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer. Int J Oncol. 2012;41(4):1337\u201346. https:\/\/doi.org\/10.3892\/ijo.2012.1559.","journal-title":"Int J Oncol"},{"issue":"3","key":"805_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.32604\/or.2024.051589","volume":"33","author":"M HU","year":"2025","unstructured":"HU M, FANG Z, SHAO Y, YAN J. Biological roles and molecular mechanism of circular RNAs in epithelial-mesenchymal transition of gastrointestinal malignancies. OR. 2025;33(3):549\u201366. https:\/\/doi.org\/10.32604\/or.2024.051589.","journal-title":"OR"},{"issue":"4","key":"805_CR50","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.molcel.2014.01.030","volume":"53","author":"K Kato","year":"2014","unstructured":"Kato K, Nakajima K, Ui A, Muto-Terao Y, Ogiwara H, Nakada S. Fine-Tuning of DNA Damage-Dependent Ubiquitination by OTUB2 Supports the DNA Repair Pathway Choice. Mol Cell. 2014;53(4):617\u201330. https:\/\/doi.org\/10.1016\/j.molcel.2014.01.030.","journal-title":"Mol Cell"},{"issue":"1","key":"805_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/thno.29545","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Cheng D, Zhu M, et al. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT\/mTOR signaling pathway in non-small cell lung cancer. Theranostics. 2019;9(1):179\u201395. https:\/\/doi.org\/10.7150\/thno.29545.","journal-title":"Theranostics"},{"key":"805_CR52","doi-asserted-by":"publisher","unstructured":"Zhu W, Wu C, Liu Z, Zhao S, Huang J. OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression. Cell Commun Signal. 2024;22(1). https:\/\/doi.org\/10.1186\/s12964-024-01789-2.","DOI":"10.1186\/s12964-024-01789-2"},{"issue":"1","key":"805_CR53","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41388-021-02071-2","volume":"41","author":"S Yu","year":"2021","unstructured":"Yu S, Zang W, Qiu Y, Liao L, Zheng X. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis. Oncogene. 2021;41(1):46\u201356. https:\/\/doi.org\/10.1038\/s41388-021-02071-2.","journal-title":"Oncogene"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00805-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00805-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00805-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:13:01Z","timestamp":1783296781000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00805-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["805"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00805-4","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research involving human participants: All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committee (the Clinical Ethics Committee of Harbin Medical University Cancer Hospital and with the 1964 Helsinki Declaration and its later amendments. The study was approved by the ethics committee. Informed consent was obtained from all individual participants included in the study. Research involving animals: All animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Ethics Committee of Harbin Medical University Cancer Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"119"}}